Omixon and Knome partner to offer advanced HLA typing for whole genome!

05/06/2013

We have great news today as Omixon Biocomputing and Knome has become partners to offer advanced HLA typing for whole genome and exome level data. We believe that this partnership will help us “discover safer and more efficient therapies by identifying genomic biomarkers for drug response and adverse response,”...

Omixon is attending TCGC in San Francisco. Meet us there!

20/05/2013

The Clinical Genome Conference (TCGC) 2013 brings together many constituencies for frank and vital discussion of the applications, questions and solutions surrounding clinical genome analysis, including scientists, physicians, diagnosticians, genetic counselors, bioinformaticists, ethicists, regulators, insurers, lawyers, and administrators. Omixon is exhibiting at TCGC in San Francisco, from 25th to...

Omixon at ESHG in Paris

05/05/2013

Omixon is going to exhibit at the annual meeting of the European Society for Human Genetics in Paris, France, 8-11 June 2013. The conference will cover all aspects of human genetics, from the cutting edge of research into the human genome and individual genetic or chromosomal conditions, right through...

Omixon at EFI conference in Maastricht

16/04/2013

Omixon is presenting and exhbiting at EFI European Immunogenetics and Histocompatibility Conference in Maastricht, The Netherlands, 11-14th May. Our CEO, Attila Berces is going to present our technology and solution for experts working in medical fields related to HLA.

Meet us at the biggest bioinformatics expo, BioIT World in Boston

05/03/2013

We are happy to tell you that we are attending the BioIT World conference in Boston, 9-11 April. Omixon will be exhibiting at booth No. 337.